Backgroud: Recent trials suggest sodium-glucose cotransporter 2 inhibitors (SGLT2i) significantly reduced proteinuria in patients with IgA nephropathy (IgAN). While little was known its efficacy in clinical practice especially in those already received full dose reninangiotensin-aldosterone system (RAAS) inhibitors.

Methods: A cohort of 93 Chinese patients with biopsy-proven IgAN and persistent proteinuria underwent full supportive therapy, including optimal blood pressure control and full dose angiotensin-converting enzyme-inhibitor or angiotensin receptor blocker therapy. Proteinuria reduction at three and six months after initiating SGLT2i therapy was analyzed.

Results: A total of 93 patients were enrolled in this study and 62 of them completed the six-month follow-up. After SGLT2i administration, a significant reduction in proteinuria was observed, with a decrease of 22.9% ( < 0.001) at three months and 27.1% ( < 0.001) at six months. During the six-month follow-up period, a decline of 3.0 mL/min/1.73m in estimated glomerular filtration rate (eGFR) ( = 0.012) and an increase of 0.8 g/L in albumin ( = 0.017) were observed. The anti-hypertensive effect of SGLT2i was not significant ( > 0.05). Notably, a consistent antiproteinuric effect of SGLT2i was observed across various settings, including different age groups, baseline levels of proteinuria/eGFR, use of immunosuppressive agents, and the presence of comorbid diabetes and hypertension (all values >0.05).

Conclusion: The proteinuria was significantly reduced after SGLT2i administration in IgAN patients with full dose angiotensin-converting enzyme-inhibitor or angiotensin receptor blocker therapy. Importantly, the antiproteinuric effect of SGLT2i was observed independently of immunosuppressive agent therapy, age, baseline eGFR and proteinuria levels, as well as the history of hypertension and diabetes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509766PMC
http://dx.doi.org/10.3389/fmed.2023.1242241DOI Listing

Publication Analysis

Top Keywords

full dose
12
proteinuria reduction
8
patients iga
8
iga nephropathy
8
dose angiotensin-converting
8
angiotensin-converting enzyme-inhibitor
8
enzyme-inhibitor angiotensin
8
angiotensin receptor
8
receptor blocker
8
blocker therapy
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!